Doç.Dr. Osman KÖSTEK | Doktorlarımız

Doğum Yeri

REFAHİYE

Yabancı Diller

İNGİLİZCE

Eğitim

2019Trakya Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji

2015Sağlık Bakanlığı İstanbul Medeniyet Üniversitesi Göztepe Eğtiim ve Araştırma Hastanesi, İç Hastalıkları

2010Marmara Üniversitesi, Tıp Fakültesi

Yayınlar

1.Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)

1. MAJİDOVA N, …, KÖSTEK O, ve ark. (2024). Clinicopathologic Features And Efficacy Of Induction

Chemotherapy In Nasopharyngeal Carcinoma: Real-World Experience. Oncology Research and

Treatment, Doi: 10.1159/000537988 (Yayın No: 8962305)

2. KAHRAMAN S, ..,KÖSTEK O, ve ark. (2024) . Treatment outcomes and prognostic factors in patients

with driver mutant non-small cell lung cancer and de novo brain metastases. Scientific Reports,

14, Doi: 10.1038/s41598-024-56046-w (Yayın No: 8962304)

3. KESİM S, …, KÖSTEK O, ve ark (2024). Evaluating therapeutic efficacy of extended shelf-life 90Y glass

microspheres in transarterial radioembolization for colorectal cancer: a quantitative FDG PET/CT

analysis. Nuclear Medicine Communications, 45, Doi: 10.1097/MNM.0000000000001813 (Yayın

No: 8899022)

4. KÖSTEK O,…, ve ark (2024). The prognostic factors in patients with advanced hepatocellular

carcinoma: impact of treatment sequencing. Journal of Chemotherapy, Doi:

10.1080/1120009X.2024.2305066 (Yayın No: 8962301)

5. BAYOGLU IV, …, KÖSTEK O, ve ark (2023). PNI as a Potential Add-On Biomarker to

Improve the IMDC Intermediate Prognostic Score. Journal of Clinical Medicine, 12(19), Doi:

10.3390/jcm12196420 (Yayın No: 8899023)

6. ARIKAN RUKİYE, ÖZGÜVEN SALİH, AKIN TELLİ TUĞBA, IŞIK SELVER, DEMİRCAN NAZIM CAN, BAŞOĞLU TÜYLÜ

TUĞBA, YAŞAR ALPER, ÇELEBİ ABDUSSAMET, FİLİZOĞLU NUH, SAĞIROĞLU ÜSTÜN HİLAL, TİNAY İLKER, ÖNEŞ TUNÇ,

TUROĞLU HALİL TURGUT, ERDİL TANJU YUSUF, ÖZTÜRK MEHMET AKİF, ERCELEP ÖZLEM, BAYOĞLU İBRAHİM VEDAT,

KÖSTEK OSMAN, DANE FAYSAL, YUMUK PERRAN FULDEN (2023). Prognostic significance of 18F-FDG

PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by

including 18F-FDG PET-CT parameters. Acta Radiologica, 64(5), 2040-2049., Doi:

10.1177/02841851221140504 (Yayın No: 8174715)

7. KÖSTEK O, ve ark (2023). BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast,

Ovarian, and Other Cancers.. Balkan journal of medical genetics : BJMG, 25(2), 5, Doi:

10.2478/bjmg-2022-0023 (Yayın No: 8370407)

8. KÜÇÜKARDA AHMET, GÖKYER ALİ, sayın sezin, GÖKMEN IVO, ÖZCAN ERKAN, KÖSTEK OSMAN,

HACIOĞLU MUHAMMET BEKİR, UZUNOĞLU SERNAZ, ÇİÇİN İRFAN (2022). Prognostic Factors for

Survival in Transverse Colon Cancers. Journal of Gastrointestinal Cancer, 53(1), 31-40., Doi:

10.1007/s12029-021-00675-1 (Yayın No: 7539577)

9. SARI MERVE, İLHAN YUSUF, SEZGİN GÖKSU SEMA, KÖSTEK OSMAN, TATLI ALİ MURAT, COŞKUN

HASAN ŞENOL (2022). The Relationship between Nutritional Parameters and Thrombosis Risk in

Cancer Patients. Informa UK Limited, 74(4), 1370-1375., Doi: 10.1080/01635581.2021.1952631

(Yayın No: 7535624)

10. AKIN TELLİ TUĞBA, ÖZTÜRK MEHMET AKİF, ALAN ÖZKAN, Hasanov Rahib, KÖSTEK OSMAN, ARIKAN

RUKİYE, BAŞOĞLU TÜYLÜ TUĞBA, KAYA SERAP, ERCELEP ÖZLEM, AKGÜL BABACAN NALAN, DANE

FAYSAL, YUMUK PERRAN FULDEN (2022). Real-world assessment of quality-of-life in patients with

breast cancer treated with adjuvant endocrine therapy. Future Medicine Ltd, 18, Doi: 10.2217/fon2021-1322 (Yayın No: 8174917)

11. BAŞOĞLU TÜYLÜ TUĞBA, ÖZGÜVEN SALİH, ŞAHİN ÖZKAN HÜLYA, ÇİNAR MERVE, KÖSTEK OSMAN,

DEMİRCAN NAZIM CAN, ARIKAN RUKİYE, AKIN TELLİ TUĞBA, ERCELEP ÖZLEM, KAYA HANDAN, ÖNEŞ

TUNÇ, ERDİL TANJU YUSUF, UĞURLU MUSTAFA ÜMİT, DANE FAYSAL, YUMUK PERRAN FULDEN

(2022). Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast

cancer patients treated with neoadjuvant chemotherapy. Elsevier BV, 41, Doi:

10.1016/j.remnie.2021.05.007 (Yayın No: 8174954),

12.AKTÜRK ESEN SELİN, ERGÜN YAKUP, EROL CİHAN, ARIKAN RUKİYE, ER MUHAMMED MUHİDDİN, atcı

muhammet mustafa, TOPÇU ATAKAN, UÇAR GÖKHAN, AKAGÜNDÜZ BARAN, AYKAN MUSA BARIŞ,

ÖZEN MİRAÇ, Köse Baytemur Naziyet, ÖZÇELİK MELİKE, ŞAHİN ELİF, GÜVEN DENİZ CAN, MENEKŞE

SERKAN, AK NAZİYE, TEKER FATİH, KUT ENGİN, ŞAKALAR TEOMAN, ALAN ÖZKAN, KAÇAN TURGUT,

TURHAL NAZIM SERDAR, KILIÇKAP SAADETTİN, TÜRKER SEMA, ŞENDUR MEHMET ALİ NAHİT,

KÖSTEK OSMAN, KARAAĞAÇ MUSTAFA, SAKİN ABDULLAH, TÜRK HACI MEHMET, ÇAĞLAYAN DİLEK,

CİHAN ŞENER, AÇIKGÖZ YUSUF, UNCU DOĞAN (2022). First-line treatment of patients with HER2-

positive metastatic gastric and gastroesophageal carcinoma. Association of Basic Medical

Sciences of FBIH, Doi: 10.17305/bjbms.2021.7069 (Yayın No: 8174893)

13. AKIN TELLİ TUĞBA, BUĞDAYCI ONUR, ALAN ÖZKAN, Sariyar Nisanur, IŞIK SELVER, ARIKAN RUKİYE,

YAŞAR ALPER, Majidova Nargiz, ÇELEBİ ABDUSSAMET, EROL BÜLENT, ÖZGEN ZERRİN, KÖSTEK

OSMAN, BAYOĞLU İBRAHİM VEDAT, ERCELEP ÖZLEM, DANE FAYSAL, YUMUK PERRAN FULDEN

(2022). Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and

Postoperative Complications in Patients with Soft Tissue Sarcoma. Informa UK Limited, 74, Doi:

10.1080/01635581.2022.2063349 (Yayın No: 8174989)

14. GÖKYER ALİ, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, GÖKMEN IVO, ÖZCAN ERKAN, sayın sezin,

TAŞTEKİN EBRU, HACIOĞLU MUHAMMET BEKİR, ERDOĞAN BÜLENT, UZUNOĞLU SERNAZ, ÇİÇİN

İRFAN (2022). Comparison of real-life data from patients with NGS panel negative and KRAS

mutation positive metastatic lung adenocarcinoma. Tumori Journal, 108(2), 141-146., Doi:

10.1177/0300891621996448 (Yayın No: 7539740)

15. AYHAN MURAT, ABAMOR EVRİM, Coban Kokten Sermin, ODABAŞ HATİCE, TATAROĞLU ÖZYÜKSELER

DENİZ, KÖSTEK OSMAN, TURAN NEDİM, Kucukoz Uzun Aysun, YILDIRIM MAHMUT EMRE (2022).

Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy

in Locally Advanced Breast Cancer. Kare Publishing, Doi: 10.14744/ejmi.2022.43076 (Yayın No:

8182098)

16. ERDOĞAN BÜLENT, KÖSTEK OSMAN, HACIOĞLU MUHAMMET BEKİR, GÖKYER ALİ, KÜÇÜKARDA

AHMET, ÖZCAN ERKAN, GÖKMEN IVO, UZUNOĞLU SERNAZ, ÇİÇİN İRFAN (2021). Is early change in

systemic inflammatory markers associated

with treatment response in patients who received pazopanib?. Journal of BUON, 2196-2201. (Yayın

No: 7532667)

17. ÖZEKİN MEHMET ENGİN, GÖKYER ALİ, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, İşsever Kubilay,

ERDOĞAN BÜLENT (2021). The association between post-progression survival and clinical

characteristics of patients with metastatic colon cancer: A single center experience. Journal of

BUON, 26(5), 1887-1892. (Yayın No: 7535595)

18. TOPAL ALPER, sayın sezin, GÖKYER ALİ, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, HACIOĞLU

MUHAMMET BEKİR, UZUNOĞLU SERNAZ, ERDOĞAN BÜLENT, ÇİÇİN İRFAN (2021). Real-life data on

first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single

center experience. Journal of BUON, 26(4), 1628-1634. (Yayın No: 7535613)

19. BAHÇECİ AYKUT, PAYDAŞ SEMRA, AK NAZİYE, FERHATOĞLU FERHAT, SAİP PINAR MUALLA,

SEYDAOĞLU GÜLŞAH, BİLİCİ MEHMET, ŞİMŞEK MELİH, TEKİN SALİM BAŞOL, ÇALIKUŞU ZÜLEYHA,

YAVUZ SİNAN, ŞAHİN AHMET BİLGEHAN, ÇUBUKÇU ERDEM, EVRENSEL TÜRKKAN,

DEĞİRMENCİOĞLU SERKAN, DEMİRAY ATİKE GÖKÇEN, YUMUK PERRAN FULDEN, ALAN ÖZKAN,

ÇIKMAN DUYGU İLKE, DEMİRELLİ FUAT HULUSİ, KÖSTEK OSMAN, GÖKYER ALİ, DOĞAN MUTLU, BAL

ÖZNUR, ÇAKAR BURCU, GÖKMEN ERHAN, YAMAÇ DENİZ, KORKMAZ TANER, ALIYEV ALTAY, KESKİN

ÖZGE, URVAY SEMİHA, BÜYÜKŞİMŞEK MAHMUT, KARADENİZ CEMİLE, YILDIZ BİROL, YEŞİL ÇINKIR

HAVVA, DEMİR HACER, BEYPINAR İSMAİL, KARAÇİN CENGİZ, ESER KADİR, BAYKARA MELTEM,

KILIÇKAP SAADETTİN, OKUTUR SADİ KEREM, BULUT GÜLCAN, ALKAN ALİ, ARPACI ERKAN, PİLANCI

KEZBAN NUR, DEMİR ATAKAN, IŞIK DENİZ, YILDIRIM NİLGÜN (2021). Efficacy and Safety of

Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience. Cancer

Investigation, 39, 473-481., Doi: 10.1080/07357907.2021.1933011 (Yayın No: 7539719)

20. GÖKYER ALİ, KÜÇÜKARDA AHMET, KÖSTEK OSMAN, sayın sezin, CAN NURAY, HACIOĞLU

MUHAMMET BEKİR, ERDOĞAN BÜLENT, UZUNOĞLU SERNAZ, ÇİÇİN İRFAN (2021). The relation

between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment.

Journal of BUON, 26(3), 1034-1039. (Yayın No: 7539594)

21. AYHAN MURAT, ODABAŞ HATİCE, TURAN NEDİM, TATAROĞLU ÖZYÜKSELER DENİZ, KÖSTEK

OSMAN, ALKAN GÜLİN, ABAMOR EVRİM, YILDIRIM MAHMUT EMRE (2021). Factors affecting the

mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience.

Journal of Chemotherapy, 33(7), 499-508., Doi: 10.1080/1120009X.2021.1923153 (Yayın No:

7539627)

22. KÜÇÜKARDA AHMET, GÖKYER ALİ, GÖKMEN IVO, HACIOĞLU MUHAMMET BEKİR, KÖSTEK OSMAN,

KURT NAZMİ, KARABULUT DERYA, TUNÇBİLEK NERMİN, UZUNOĞLU SERNAZ, ERDOĞAN BÜLENT,

ÇİÇİN İRFAN (2021). Skeletal muscle loss during anti-epidermal growth factor receptor therapy is

an independent prognostic factor on non-small cell lung cancer patients survival. Journal of BUON,

26(3), 853-860. (Yayın No: 7539607)

23.TURAL DENİZ, ÖLMEZ ÖMER FATİH, SÜMBÜL AHMET TANER, ÖZHAN NAİL, ÇAKAR BURCU, KÖSTEK

OSMAN, EKENEL MELTEM, ERMAN MUSTAFA, COŞKUN HASAN ŞENOL, SELÇUKBİRİCİK FATİH, KESKİN ÖZGE, PAKSOY TÜRKÖZ FATMA, ORUÇ KEREM, BAYRAM SELAMİ, BİLGETEKİN İREM, YILDIZ

BİROL, ŞENDUR MEHMET ALİ NAHİT, PAKSOY NAİL, DİRİCAN AHMET, ERDEM DİLEK, SELAM MELTEM,

TANRIVERDİ ÖZGÜR, PAYDAŞ SEMRA, URAKÇI ZUHAT, ATAĞ ELİF, GÜNCAN SABRİ, ÜRÜN YÜKSEL,

ALKAN ALİ, KAYA ALİ OSMAN, TATAROĞLU ÖZYÜKSELER DENİZ, TAŞKAYNATAN HALİL, YILDIRIM

MUSTAFA, SÖNMEZ BEDRİYE MÜGE, BAŞOĞLU TÜYLÜ TUĞBA, GÜNDÜZ ŞEYDA, KILIÇKAP

SAADETTİN, ARTAÇ MEHMET (2021). Prognostic factors in patients with metastatic urothelial

carcinoma who have treated with Atezolizumab. International Journal of Clinical Oncology, 26, Doi:

10.1007/s10147-021-01936-6 (Yayın No: 7539666)

24. AYHAN MURAT, TURAN NEDİM, KÖSTEK OSMAN, TUFAN GÜLNİHAL, TATAROĞLU ÖZYÜKSELER

DENİZ, ODABAŞ HATİCE, SAKİN ABDULLAH, TURAN MERVE, sürmeli heves, YILDIRIM MAHMUT EMRE

(2021). Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal

cancer patients who had mucinous pathology compared to those who had non-mucinous

pathology?. Current Problems in Cancer, 45, Doi: 10.1016/j.currproblcancer.2020.100670 (Yayın

No: 7539758)

25. HACIBEKİROĞLU İLHAN, ÖZKUL ÖZLEM, ÇAKIR EMRE, KÖSTEK OSMAN, KARATAŞ FATİH, ESENKAYA

ASIM, DEMİRCİ AYŞE, BİLİR CEMİL (2021). Comparative assessment of three different second-line

regimens in chemotherapy resistant / refractory small-cell

lung cancer. Journal of BUON, 26(1), 79-86. (Yayın No: 7539732)

26. DEMİR TARIK, ALIYEV ALTAY, BEŞİROĞLU MEHMET, ARAZ MURAT, KÖSTEK OSMAN, SAKİN

ABDULLAH, SHBAİR ABDALLAH T M, ÇOBAN GANİME, ERSÖZ CEVPER, ŞEKER MESUT, TÜRK HACI

MEHMET (2021). Is lymph node dissection necessary for staging while undergoing nephrectomy in

patients with renal cell carcinoma?. Current Problems in Cancer, 45, Doi:

10.1016/j.currproblcancer.2020.100619 (Yayın No: 7539764)

27. KARADAĞ AYŞE SERAP,CHEN WEN CHIEH,UZUNÇAKMAK TUĞBA KEVSER,ÖZLÜ EMİN,TAKIR

MÜMTAZ,KARADAĞ REMZİ,KÖSTEK OSMAN,ŞİMŞEK MEHMET,AKDENİZ NECMETTİN,WOLLINA UWE

(2020). Introduction of a novel quantitative scoring systemfor acanthosis nigricans and its

validation in a pilot study. Dermatologic Therapy, Doi: 10.1111/dth.14450 (Yayın No: 6666504)

28. KORKMAZ ÜLKÜ,HACIOĞLU MUHAMMET BEKİR,KÖSTEK OSMAN,SÜT NECDET,KODAZ

HİLMİ,ERDOĞAN BÜLENT,ÜSTÜN FUNDA,SAYNAK MERT,TAŞTEKİN EBRU,ÇİÇİN İRFAN,ALTUN GÜLAY

(2020). The relationship between FDG PET/CT-defined metabolic parameters and the

histopathological subtype of oesophageal carcinomas. Polish Journal of Radiology, 85(1), 254-260.,

Doi: 10.5114/pjr.2020.95945 (Yayın No: 6380485)

29. VURAL KESKİNLER MİRAÇ, KÖSTEK OSMAN, EROK BERRİN, TELCİ ÇAKLILI ÖZGE, DANACIOĞLU

YAVUZ ONUR, OĞUZ AYTEKİN (2020). Perioperative Myocardial Damage and The Incidence of Type

2 Myocardial Infarction in Patients with Intermediate and High Cardiovascular Risk. The Anatolian

Journal of Cardiology, 25(2), 89-95., Doi: 10.14744/AnatolJCardiol.2020.45752 (Yayın No: 7539752)

30. Caliskan Zuhal,TELCİ ÇAKLILI ÖZGE,KAHRAMAN RESUL,Ozcan Fatma Betul,Sayar Suleyman,KÖSTEK

OSMAN,DEMİRCİOĞLU KENAN,Yilmaz Yusuf,KUL Seref,ÇALIŞKAN MUSTAFA (2019). Does celiac

disease impair coronary microvascular circulation: Coronary flow velocity reserve of patients with

celiac disease. Echocardiography, Doi: 10.1111/echo.14554 (Yayın No: 5572092)

31. Köstek Osman, Demircan Nazım Can, Gökyer Ali, Küçükarda Ahmet, Sunal Baran Serdar, Hacıoğlu

Muhammet Bekir, Eslame Hosna, Solak Serdar, Yılmaz Erdem, Uzunoğlu Sernaz, Tunçbilek Nermin,

Çiçin İrfan, Erdoğan Bülent (2019). Skeletal muscle loss during anti-EGFR combined chemotherapy

regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer. Clinical

and Translational Oncology, 21(11), 1510-1517., Doi: 10.1007/s12094-019-02079-x (Yayın No:

5076305)

32. HACIOĞLU MUHAMMET BEKİR,KÖSTEK OSMAN,KURT NAZMİ,KÜÇÜKARDA AHMET,GÖKYER

ALİ,USTABAŞIOĞLU FETHİ EMRE,KARATAŞ FATİH,TUNÇBİLEK NERMİN,UZUNOĞLU SERNAZ,BİLİCİ

AHMET,ÇİÇİN İRFAN,ERDOĞAN BÜLENT (2019). Comparison of skeletal muscle mass loss in

patients withmetastatic colorectal cancer treated with regorafenib orTAS-102. Journal of BUON,

24(5), 2198-2204. (Yayın No: 5408241)

33. BOZKAYA YAKUP,KÖSTEK OSMAN,SAKİN ABDULLAH,TATAROĞLU ÖZYÜKSELER DENİZ,ŞAKALAR

TEOMAN,ÇİL İBRAHİM (2019). Is the prognostic nutritional index a prognostic and predictive factor

in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?. Supportive

Care in Cancer, Doi: 10.1007/s00520-019-05055-x (Yayın No: 5297159)

34. KÖSTEK OSMAN,BOZKAYA YAKUP,HACIOĞLU MUHAMMET BEKİR,Yıldırım Özdemir Nuriye,Yılmaz

Erdem,DEMİRCAN NAZIM CAN,ERDOĞAN BÜLENT,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN,ZENGİN

NURULLAH (2019). Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and

Mortality in Elderly Patients with Locally Advanced Rectal Cancer?. Archives of Iranian Medicine,

22(5), 236-241. (Yayın No: 5378182)

35. Köstek Osman, Yılmaz Erdem, Hacıoğlu Muhammet Bekir, Demircan Nazım Can, Gökyer Ali,

Uzunoğlu Sernaz, Tunçbilek Nermin, Çiçin İrfan, Erdoğan Bülent (2019). Changes in skeletal

muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer.

Cancer Chemotherapy and Pharmacology, 83(4), 735-742., Doi: 10.1007/s00280-019-03779-5

(Yayın No: 4821125)

36. Gökyer Ali, Küçükarda Ahmet, Köstek Osman, Hacıoğlu Muhammet Bekir, Sunal Baran Serdar,

Demircan Nazım Can, Uzunoğlu Sernaz, Solak Serdar, İşsever Kubilay, Çiçin İrfan, Erdoğan Bülent

(2019). Relation between sarcopenia and dose-limiting toxicity in patients with metastatic

colorectal cancer who received regorafenib. Clinical and Translational Oncology, 21(11), 1518-

1523., Doi: 10.1007/s12094-019-02080-4 (Yayın No: 5386755)

37. Bozkaya Yakup,Erdem Gökmen Umut,Demirci Nebi Serkan,Yazıcı Ozan,Özdemir Nuriye

Yıldırım,KÖSTEK OSMAN,Zengin Nurullah (2019). Prognostic importance of the albumin to globulin

ratio in metastatic gastric cancer patients. Current Medical Research and Opinion, 35(2), 275-282.,

Doi: 10.1080/03007995.2018.1479683 (Yayın No: 4407381)

38. GÖKYER ALİ,KÜÇÜKARDA AHMET,KÖSTEK OSMAN,Sunal B S,Solak S,İşsever K,ÇİÇİN

İRFAN,UZUNOĞLU SERNAZ,ERDOĞAN BÜLENT,DEMİRCAN NAZIM CAN (2019). Relation between

sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received

regorafenib. Clinical and Translational Oncology, Doi: 10.1007/s12094-019-02080-4 (Yayın No:

4968265)

39. KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR,SAKİN ABDULLAH,DEMİR TARIK,SARI MURAT,ÖZKUL

ÖZLEM,ARAZ MURAT,DOĞAN AYSUN FATMA,DEMİRCAN NAZIM CAN,UZUNOĞLU SERNAZ,ÇİÇİN

İRFAN,ERDOĞAN BÜLENT (2019). Regorafenib or rechallenge chemotherapy: Which is more

effective in the third-line treatment of metastatic colorectal cancer?. CANCER CHEMOTHERAPY

AND PHARMACOLOGY, 83(1), 115-122., Doi: 10.1007/s00280-018-3713-6 (Yayın No: 4427707)

40. Çelik Mehmet,AKYER ERDAL,YORULMAZ ELİF,ÇİFTÇİ HİLMİ,ÇAKICI VELİ,KÖSTEK OSMAN (2018).

Investigation of prevalence of insulin resistance and metabolic syndrome in patients with gastric

and colon carcinoma. Eurasian Journal of Medical Investigation, 2(3), 168-171., Doi:

10.14744/ejmi.2018.64936 (Yayın No: 4407383)

41. Yilmaz Erdem,KÖSTEK OSMAN,Hereklioglu Savas,Goktas Muhammet,Tuncbilek Nermin (2018).

Assessment of Duodenal Diverticula: Computed Tomography Findings. Current Medical Imaging

Reviews, 14, Doi: 10.2174/1573405614666180904123526 (Yayın No: 4407379)

42. Korucu Fatma Ceyda,Senyigit Ece,KÖSTEK OSMAN,Demircan Nazım Can,Erdogan Bulent,Uzunoglu

Sernaz,ÇİÇİN İRFAN (2018). A retrospective study on potential drug interactions: A single center

experience. Journal of Oncological Sciences, 4(2), 80-84., Doi: 10.1016/j.jons.2018.06.001 (Yayın

No: 4407380)

43. KÖSTEK OSMAN,YILMAZ ERDEM,HACIOĞLU MUHAMMET BEKİR,ERDOĞAN BÜLENT,KODAZ

HİLMİ,BEKMEZ ESMA TURKMEN,HACIBEKİROĞLU İLHAN,UZUNOĞLU SERNAZ,TUNCBİLEK

NERMİN,ÇİÇİN İRFAN (2018). Value of MRI apparent diffusion coefficient for assessment of

response to sorafenib in hepatocellular carcinoma. Journal of BUON, 23(4), 979-984.

44. BOZKAYA YAKUP,YILDIRIM ÖZDEMİR NURİYE,SEZER SEVİLAY,KÖSTEK OSMAN,DEMİRCİ NEBİ

SERKAN,YAZICI OZAN,ERDEM GÖKMEN UMUT,EREN TÜLAY,ZENGİN NURULLAH (2018). Is serum

survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with

neoadjuvant chemotherapy?. Cancer biomarkers : section A of Disease markers, 22(1), 143-149.,

Doi: 10.3233/CBM-171119 (Yayın No: 4227729)

45. ERDOĞAN BÜLENT,KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR (2018). Enzalutamide in Prostate

Cancer, A Review on Enzalutamide and cancer. Eurasian Journal of Medicine and Oncology, 2(3),

121-129., Doi: 10.14744/ejmo.2018.72098 (Yayın No: 5299101)

46. CAN NURAY,TAŞTEKİN EBRU,YALTA TÜLİN DENİZ,SÜT NECDET,KORKMAZ SELMA,USTA UFUK,ÖZ

PUYAN FULYA,GENÇ EZGİ,CEZİK MERT,BİNBOĞA TUTUĞ BUSEM,KÖSTEK OSMAN,TOZKIR HİLMİ

(2018). BRAF V600 mutation profile of metastatic melanoma in the Thrace region of Turkey.

Turkish Journal of Pathology (Yayın No: 4178999)

47. Bozkaya Yakup,Özdemir Nuriye Yıldırım,Erdem Gökmen Umut,Güner Ebru Karcı,Ürün

Yüksel,Demirci Nebi Serkan,Yazıcı Ozan,KÖSTEK OSMAN,Zengin Nurullah (2018). Clinical

predictive factors associated with pathologic complete response in locally advanced rectal cancer.

Journal of Oncological Sciences, 4(1), 5-10., Doi: 10.1016/j.jons.2017.12.004 (Yayın No: 4407384)

48. CAN NURAY,TAŞTEKİN EBRU,YALTA TÜLİN DENİZ,SÜT NECDET,Korkmaz Selma,USTA UFUK,ÖZ

PUYAN FULYA,Genç Ezgi,CEZİK MERT,Tutuğ Busem Binboğa,KÖSTEK OSMAN,TOZKIR HİLMİ (2018).

Braf v600 mutation profile of metastatic melanoma in the thrace region of Turkey. Turkish Journal

of Pathology, 34(2), 134-142., Doi: 10.5146/tjpath.2018.01422 (Yayın No: 5386887)

49. KANBAY ASİYE,CEYLAN ERKAN,İNÖNÜ KÖSEOĞLU HANDAN,ÇALIŞKAN MUSTAFA,TAKIR

MÜMTAZ,TULU SELCAN,ÇAKLILI TELCİ ÖZGE,KÖSTEK OSMAN,EREK AYBALA,AFŞAR BARIŞ (2018).

Endocan: a Novel Predictor of Endothelial Dysfunction in Obstructive Sleep Apnea Syndrome. The

Clinical Respiratory Journal, 12(1), 84-90., Doi: 10.1111/crj.12487 (Yayın No: 4414926)

50. ESİN ECE,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,BİLİCİ AHMET,ÇİÇİN İRFAN,KÖSTEK OSMAN,kaplan

muhammed ali,AKSOY SERCAN,özdemir özlem,ALACACIOĞLU AHMET,ÇABUK DEVRİM,SÜMBÜL

AHMET TANER,SAKİN ABDULLAH,PAYDAŞ SEMRA,YETİŞİR EVREN,ER ÖZLEM,yıldırım nilgün,sakalar

teoman,DEMİR HACER,KARAAĞAÇ MUSTAFA,HARPUTLUOĞLU HAKAN,BİLEN ERKAN,Erdur

Erkan,DEĞİRMENCİOĞLU SERKAN,Aliyev Altay,ÇİL TİMUÇİN,Olgun Polat,BAŞARAN GÜL,GÜMÜŞAY

ÖZGE,DEMİR ATAKAN,tanrıkulu eda,YUMUK PERRAN FULDEN,Gökşen İnanç,OYAN ULUÇ

BAŞAK,Çetin Bülent,haksöyler veysel,KARADURMUŞ NURİ,Erturk Ismail,yılmaz hülya,BEYPINARMURAT,pilancı kezban nur,ŞEKER MEHMET METİN,yıldırım nuriye,Eren Tülay,DEMİRCİ UMUT (2018).

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumabnaïve breast cancer: real-life practice outcomes. Cancer Chemotherapy and Pharmacology, 83(1),

131-143., Doi: 10.1007/s00280-018-3712-7 (Yayın No: 4425120)

51. KANTER MEHMET,AKSU FEYZA,TAKIR MÜMTAZ,KÖSTEK OSMAN,KANTER BETÜL,OYMAGİL ALİ

(2017). Effects of Low Intensity Exercise Against Apoptosis and Oxidative Stress in Streptozotocininduced Diabetic Rat Heart. Experimental and Clinical Endocrinology Diabetes, 125(09), 583-591.,

Doi: 10.1055/s-0035-1569332 (Yayın No: 4240030)

52. ÖNAL YILMAZ,KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR,ERDOĞAN BÜLENT,KODAZ

HİLMİ,TÜRKMEN BEKMEZ ESMA,HACIBEKİROĞLU İLHAN,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN (2017).

Assessment of prognostic factors in epithelial ovarian cancer. Eurasian Journal of Medicine and

Oncology, 1(2), 61-68., Doi: 10.14744/ejmo.2017.43531 (Yayın No: 5301481)

53. KANBAY ASİYE,Demir Neslihan Cerrah,TUTAR NURİ,KÖSTEK OSMAN,Özer Şimşek Zuhal,Büyükoğlan

Hakan,Demir Ramazan,Parrino Liborio (2017). The effect of CPAP therapy on insulin-like growth

factor and cognitive functions in obstructive sleep apnea patients. The Clinical Respiratory Journal,

11(4), 506-513., Doi: 10.1111/crj.12365 (Yayın No: 5387086)

54. KODAZ HİLMİ,KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR,ERDOĞAN BÜLENT,KODAZ ELPEN

ÇAĞNUR,HACIBEKİROĞLU İLHAN,TÜRKMEN ESMA,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN (2017).

Frequency of RAS Mutations (KRAS, NRAS, HRAS) in Human Solid Cancer. Eurasian Journal of

Medicine and Oncology, 1(1), 1-7., Doi: 10.14744/ejmo.2017.22931 (Yayın No: 5306427)

55. Alpaydin Sertaç,Turan Yasar,ÇALIŞKAN MUSTAFA,ÇALIŞKAN ZUHAL,AKSU FEYZA,ÖZYILDIRIM

SERHAN,BUYUKTERZİ ZAFER,KÖSTEK OSMAN,MÜDERRİSOĞLU İBRAHİM HALDUN (2017). Morning

blood pressure surge is associated with carotid intima-media thickness in prehypertensive

patients. Blood Pressure Monitoring, 22(3), 131-136., Doi: 10.1097/MBP.0000000000000252

(Yayın No: 5387245)

56. TAKIR MÜMTAZ,ÖZLÜ EMİN,KÖSTEK OSMAN,TÜRKOĞLU ZAFER,MUTLU HASAN

HÜSEYİN,UZUNÇAKMAK TUĞBA KEVSER,AKDENİZ NECMETTİN,KARADAĞ AYŞE SERAP (2017). Skin

Findings in Autoimmune and Nonautoimmune Thyroid Disease with Respect to Thyroid Functional

Status and Healthy Controls. Turkish Journal of Medical Sciences, 47, 764-770., Doi: 10.3906/sag1510-39 (Yayın No: 4239614)

57. HACIOĞLU MUHAMMET BEKİR,KODAZ HİLMİ,ERDOĞAN BÜLENT,ÇİNKAYA AHMET,TAŞTEKİN

EBRU,HACIBEKİROĞLU İLHAN,TÜRKMEN ESMA,KÖSTEK OSMAN,GENÇ EZGİ,UZUNOĞLU

SERNAZ,ÇİÇİN İRFAN (2017). K-RAS and N-RAS mutations in testicular germ cell tumors. Bosnian

Journal of Basic Medical Sciences, 17(2), 159-163., Doi: 10.17305/bjbms.2017.1764

58. HACIOĞLU MUHAMMET BEKİR,KÖSTEK OSMAN,ERDOĞAN BÜLENT,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN

(2017). Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer

even with brain metastasis. Journal of BUON, 22(3), 586-591. (Yayın No: 4207310)

59. Aksu Feyza,ÇALIŞKAN MUSTAFA,Keles Nursen,Erek Toprak Aybala,Uzuncakmak Tugba

Kevser,KÖSTEK OSMAN,Yilmaz Yusuf,Demircioglu Kenan,Cekin Esad,Ozturk Ibrahim,KARADAĞ AYŞE

SERAP (2017). Chemerin as a marker of subclinical cardiac involvement in psoriatic patients.

Cardiology Journal, 24(3), 276-283., Doi: 10.5603/CJ.a2017.0031 (Yayın No: 5387340)

60. TAKIR MÜMTAZ,BAKAN Ali,TAYMAZ TAHRA Sema,KÖSTEK OSMAN,Erek Aybala,DURAN İlyas,BAKAN

Sibel,Elcioglu Ömer Celal,AYDIN BAHAT Kübra,Odabas Ali Riza,KANBAY MEHMET (2017). Bone

Mineral Density and Osteoporosis in Hyponatremic Versus Normonatremic Patients: A

Retrospective 12-Month Analysis. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION

JOURNAL, 26(1), 29-34., Doi: 10.5262/tndt.2017.1001.05 (Yayın No: 4388119)

61. Ozulku Mehmet,ÇALIŞKAN MUSTAFA,Saba Tonguc,Aksu Feyza,Ciftci Ozgur,Gullu Hakan,Guven

Aytekin,KÖSTEK OSMAN,Caklili Ozge Telci,Aslamaci Sait,Muderrisoglu Haldun (2016). The

Influence of On-pump Versus Off-pump Surgery on Short- and Medium-term Postoperative

Coronary Flow Reserve After Coronary Artery Bypass Grafting. Heart, Lung and Circulation, 25(12),

1232-1239., Doi: 10.1016/j.hlc.2016.02.012 (Yayın No: 4405038)

62. Takir Mumtaz,Unal Aslı Dogruk,KÖSTEK OSMAN,Bayraktar Nilufer,Demirag Nilgun Guvener (2016).

Cystatin-C and TGF-β levels in patients with diabetic nephropathy. Nefrología, 36(6), 653-659.,

Doi: 10.1016/j.nefro.2016.06.011 (Yayın No: 4405040)

63. Caliskan Zuhal,Keles Nursen,Gokturk Huseyin Savas,Ozdil Kamil,Aksu Feyza,Ozturk Oguzhan,Resul

Kahraman,KÖSTEK OSMAN,Tekin Ahmet S,Ozgur Gulsum Teke,ÇALIŞKAN MUSTAFA (2016). Is

activation in inflammatory bowel diseases associated with further impairment of coronary

microcirculation?. International Journal of Cardiology, 223, 176-181., Doi:

10.1016/j.ijcard.2016.08.141 (Yayın No: 4405044)

64. ÇALIŞKAN MUSTAFA,Turk Emin,Karagulle Erdal,Ciftci Ozgur,Oguz Hakan,KÖSTEK OSMAN,Moray

Gokhan,HABERAL MEHMET (2016). Coronary Flow Velocity Reserve in Burn Injury. Journal of Burn

Care Research, 37(5), 400-408., Doi: 10.1097/BCR.0000000000000302 (Yayın No: 4407365)

65. Bulut Mustafa,Keles Nursen,Caliskan Zuhal,KÖSTEK OSMAN,Aksu Feyza,Ozdil Kamil,Akcakoyun

Mustafa,Demircioglu Kenan,Yilmaz Yusuf,KANBAY MEHMET,ÇALIŞKAN MUSTAFA (2016). Is the

presence of AA amyloidosis associated with impaired coronary flow reserve?. Atherosclerosis, 251, 389-395., Doi: 10.1016/j.atherosclerosis.2016.05.041 (Yayın No: 4405048)

66. Kanter Mehmet,Takir Mumtaz,Mutlu Hasan Huseyin,Kanter Betul,KÖSTEK OSMAN,Toprak Aybala

Erek (2016). Protective Effects of Curcumin on Intestinal Damage in Cholestatic Rats. Journal of

Investigative Surgery, 29(3), 128-136., Doi: 10.3109/08941939.2015.1088604 (Yayın No: 4405065)

67. Keles Nursen,ÇALIŞKAN MUSTAFA,Dogan Burcu,Aksu Feyza,Bulur Serkan,Keles Necibe Nur,KÖSTEK

OSMAN,Aung Soe Moe,Isbilen Banu,Demircioglu Kenan,Kalcik Macit,OĞUZ AYTEKİN (2016). Is Low

Serum Klotho Level Associated with Alterations in Coronary Flow Reserve?. Echocardiography,

33(6), 881-888., Doi: 10.1111/echo.13176 (Yayın No: 4405060)

68. Elcioglu Omer Celal,Afsar Baris,Bakan Ali,Takir Mumtaz,Ozkok Abdullah,Oral Alihan,KÖSTEK

OSMAN,Basci Semih,Toprak Aybala Erek,Bahat Kubra Aydin,Kalcioglu M Tayyar,KANBAY MEHMET

(2016). Chronic Rhinosinusitis, Endothelial Dysfunction, and Atherosclerosis. American Journal of

Rhinology Allergy, 30(3), 58-61., Doi: 10.2500/ajra.2016.30.4325 (Yayın No: 4405051)

69. Bedir Osman,Kiziltas Safak,KÖSTEK OSMAN,Ozkanli Seyma (2016). The relation of presenting

symptoms with staging, grading, and postoperative 3-year mortality in patients with stage I–III

nonmetastatic colon cancer. The Turkish Journal of Gastroenterology, 27(3), 239-245., Doi:

10.5152/tjg.2016.15508 (Yayın No: 4405053)

70. Kanter M,TUNCER İLYAS,Erboga M,Atanassova P,Takir M,KÖSTEK OSMAN (2016). The effects of

quercetin on liver regeneration after liver resection in rats. Folia Morphologica, 75(2), 179-187.,

Doi: 10.5603/FM.a2015.0086 (Yayın No: 4407362)

71. Keles Nursen,Dogan Burcu,Kalcik Macit,ÇALIŞKAN MUSTAFA,Keles Necibe Nur,Aksu Feyza,Bulut

Mustafa,KÖSTEK OSMAN,Isbilen Banu,Yilmaz Yusuf,OĞUZ AYTEKİN (2016). Is serum Klotho

protective against atherosclerosis in patients with type 1 diabetes mellitus?. Journal of Diabetes

and its Complications, 30(1), 126-132., Doi: 10.1016/j.jdiacomp.2015.09.013 (Yayın No: 4405069)

72. Takir Mumtaz,KÖSTEK OSMAN,Ozkok Abdullah,Elcioglu Omer Celal,Bakan Ali,Erek Aybala,Mutlu

Hasan Huseyin,Telci Ozge,Semerci Aysun,ODABAŞ ALİ RIZA,Afsar Baris,Smits Gerard,ALanaspa

Miguel,Sharma Shailendra,Johnson Richard J,KANBAY MEHMET (2015). Lowering Uric Acid With

Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic

Hyperuricemia. Journal of Investigative Medicine, 63(8), 924-929., Doi:

10.1097/JIM.0000000000000242 (Yayın No: 4405071)

73. YILMAZ İBRAHİM,ÖZKÖK ABDULLAH,KÖSTEK OSMAN,KOLUKISA AHMET,DURAN İLYAS,ODABAŞ ALİ

RIZA,İŞMAN FERRUH KEMAL,BAŞOK BANU İŞBİLEN (2015). C-reactive protein but not hepcidin,

NGAL and transferrin determines the ESA resistance in hemodialysis patients.. Renal failure, 38(1),

89-95., Doi: 10.3109/0886022X.2015.1106896 (Yayın No: 4227719)

74. ÇALIŞKAN MUSTAFA,Turan Yasar,Caliskan Zuhal,Gullu Hakan,Ciftci Faika Ceylan,Avci Enver,Duran

Cevdet,KÖSTEK OSMAN,TELCİ ÇAKLILI ÖZGE,KOCA HARUN,KULAKSIZOĞLU MUSTAFA (2015).

Previous gestational diabetes history is associated with impaired coronary flow reserve. Annals of

Medicine, 47(7), 615-623., Doi: 10.3109/07853890.2015.1099719 (Yayın No: 4406661)

75. Keles Nursen,ÇALIŞKAN MUSTAFA,Dogan Burcu,Keles Necibe Nur,Kalcik Macit,Aksu Feyza,KÖSTEK

OSMAN,Aung Soe Moe (2015). Low Serum Level of Klotho Is an Early Predictor of Atherosclerosis.

The Tohoku Journal of Experimental Medicine, 237(1), 17-23., Doi: 10.1620/tjem.237.17 (Yayın No:

4407363)

76. Elcioglu Omer Celal,Afsar Baris,Takir Mumtaz,Toprak Aybala Erek,Bakan Ali,Bakan Sibel,KÖSTEK

OSMAN,Oral Alihan,ERMAN HAYRİYE (2015). Renalase: Another puzzle piece between hypertension

and simple renal cysts?. International Urology and Nephrology, 47(7), 1181-1186., Doi:

10.1007/s11255-015-1008-y (Yayın No: 4407368)

77. Ozturk AB,Ozyigit Pur L,KÖSTEK OSMAN,Keskin H (2015). Association between asthma selfmanagement knowledge and asthma control in the elderly. Annals of Allergy, Asthma

Immunology, 114(6), 480-484., Doi: 10.1016/j.anai.2015.04.003 (Yayın No: 4407369)

78. Keleş Nurşen,Kalçik Macit,ÇALIŞKAN MUSTAFA,Çakir Hakan,Aung Soe Moe,KÖSTEK OSMAN,İzgi

İbrahim Akin,Kirma Cevat (2015). The effects of urgent percutaneous coronary intervention on

right ventricular systolic functions in non-ST-elevation acute coronary syndromes. Interventional

Medicine and Applied Science, 7(2), 69-77., Doi: 10.1556/1646.7.2015.2.5 (Yayın No: 4407366)

79. Keles Nursen,ÇALIŞKAN MUSTAFA,Aksu Feyza Ulusoy,Keles Necibe Nur,Karagoz Vildan,Ahmet

Selami Tekin,Akcakoyun Mustafa,KÖSTEK OSMAN,Elcioglu Omer,Soe Moe Aung,Bakan Ali,ODABAŞ

ALİ RIZA (2015). Retrobulbar blood flow and carotid intima–media thickness alteration may relate

to subclinic atherosclerosis in patients with chronic inflammatory diseases. Renal Failure, 37(7),

1164-1170., Doi: 10.3109/0886022X.2015.1057469 (Yayın No: 4407367)

80. Bakan Ali,Oral Alihan,Elcioglu Omer Celal,Takir Mumtaz,KÖSTEK OSMAN,Ozkok Abdullah,Basci

Semih,Sumnu Abdullah,Ozturk Savas,Sipahioglu Murat,Turkmen Aydın,Voroneanu Luminita,Covic

Adrian,KANBAY MEHMET (2015). Hyperuricemia is associated with progression of IgA nephropathy.

International Urology and Nephrology, 47(4), 673-678., Doi: 10.1007/s11255-015-0939-7 (Yayın

No: 4407373)

81. Afsar Baris,Takir Mumtaz,KÖSTEK OSMAN,Covic Adrian,KANBAY MEHMET (2014). Endocan: A New

Molecule Playing a Role in the Development of Hypertension and Chronic Kidney Disease?. The

Journal of Clinical Hypertension, 16(12), 914-916., Doi: 10.1111/jch.12440 (Yayın No: 4407374)

82. ÇALIŞKAN MUSTAFA,Caliskan Zuhal,Gullu Hakan,Keles Nursen,Bulur Serkan,Turan Yasar,KÖSTEK

OSMAN,Ciftci Ozgur,Guven Aytekin,Aung Soe Moe,Muderrisoglu Haldun (2014). Increased morning

blood pressure surge and coronary microvascular dysfunction in patient with early stage

hypertension. Journal of the American Society of Hypertension, 8(9), 652-659., Doi:

10.1016/j.jash.2014.05.010 (Yayın No: 4407378)

83. ÇOLAK YAŞAR,YEŞİL ATAKAN,MUTLU HASAN HÜSEYİN,TELCİ ÇAKLILI ÖZGE,ULAŞOĞLU

CELAL,ŞENATEŞ EBUBEKİR,TAKIR MÜMTAZ,KÖSTEK OSMAN,YILMAZ YUSUF,YILMAZ ENÇ

FERUZE,TAŞAN GÜRALP,TUNCER İLYAS (2014). A Potential Treatment of Nonalcoholic Fatty Liver

Disease with SIRT1 Activators. Journal of Gastrointestinal and Liver Diseases, 23(3), 311-319., Doi:

10.15403/jgld.2014.1121.233.yck (Yayın No: 4407377)

84. ulasoğlu celal,mesci Banu,karagöz engin,karagöz vildan,akın yasin,öztürk hatice,işbilen

banu,şişman ferruh,KAVALA MUKADDES,KÖSTEK OSMAN,KIZILTAŞ ŞAFAK,ÇOLAK YAŞAR,TUNCER

İLYAS (2013). Frequency of metabolic syndrome and non alcoholic fatty liver in Behcet’s disease.

Nobel Medicus, 9(3), 35-42. (Yayın No: 4413502)

2.Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler

1. KÖSTEK OSMAN (2022). Immunotherapy in esophagogastric cancer. International Association of

Surgeons, Gastroenterologists and Oncologists (Tam Metin Bildiri/Davetli Konuşmacı) (Yayın No:

8193855)

2. Sağıroğlu üstün hilal, çelebi abdussamet, BAYOĞLU İBRAHİM VEDAT, ARIKAN RUKİYE, YAŞAR

ALPER, Majidova nargiz, SEVER NADİYE, SARI MURAT, IŞIK SELVER, ercelep özlem, KÖSTEK

OSMAN (2022). what is the ideal sequence for regorafenib in the treatment of metastatic

colorectal cancer?. 12TH INTERNATIONAL GASTROINTESTINAL CANCERS CONFERENCE (Tam

Metin Bildiri/Sözlü Sunum) (Yayın No: 8193826)

3. SARI MURAT, ALBAYRAK AYŞE, KÖSTEK OSMAN (2022). EVALUATION OF PROGNOSTIC

IMPORTANCE OF HISTOPATHOLOGICAL FEATURES AND TUMOR-INFILTRATING LYMPHOCYTES IN

THE TUMOR CENTER FOR SURVIVAL IN STAGE II-II OPERATED GASTRIC CANCER. 12TH

INTERNATIONAL GASTROINTESTINAL CANCERS CONFERENCE (Tam Metin Bildiri/Sözlü Sunum)

(Yayın No: 8193816)

4. ÖZEKİN MEHMET ENGİN,KÖSTEK OSMAN,ERDOĞAN BÜLENT (2019). THE ASSOCIATION

BETWEEN POST-PROGRESSION SURVIVAL AND CLINICAL CHARACTERISTICS OF THE PATIENTS

WITH METASTATIC COLORECTAL CANCER. 9. INTERNATIONAL GASTROINTESTINAL CANCER

CONFERENCE (Özet Bildiri/Sözlü Sunum) (Yayın No: 5556316)

5. IŞIK ULAŞ,ALİYEV ALTAY,DEMİR ATAKAN,TURHAL SERDAR,PİLANCI KEZBAN NUR,KEFELİ

UMUT,GÖKYER ALİ,PAYDAŞ SEMRA,UNCU DOĞAN,ÖKTEN İLKER NİHAT,UYGUN KAZIM,KÖSTEK

OSMAN,ÇABUK DEVRİM,DEMİRAY ATİKE GÖKÇEN,DİRİCAN AHMET,ŞİMŞEK MELİH,BÜYÜKŞİMŞEK

MAHMUT,UÇAR GÖKHAN,GÜNAYDIN ULUĞ MUTLU,SAKALAR TEOMAN (2019). Real life data from

Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer..

ASCO 2019, 37, 16075-16075., Doi: 10.1200/JCO.2019.37.15_suppl.e16075 (Tam Metin

Bildiri/Poster) (Yayın No: 5297257)

6. Köstek Osman, Yılmaz Erdem, Demircan Nazım Can, Gökyer Ali (2018). Changes in Lean Body

Mass and Skeletal Muscle Area During Pazopanib vs Sunitinib Therapy for Metastatic Renal Cancer.

2nd International Congress on Oncological Sciences, 98-99. (Özet Bildiri/Sözlü Sunum) (Yayın No:

4821169)

7. HACIOĞLU MUHAMMET BEKİR,KÖSTEK OSMAN (2018). METASTATİK KOLOREKTAL KANSERLERDE

REGORAFENİB ETKİNLİĞİ SAĞ-SOL FARKI VAR MI?. TREATMENT MODALITIES FOR STAGE IV

DISEASES FOR COLORECTAL CANCER 6 th MEETING (Özet Bildiri/Sözlü Sunum) (Yayın No:

5341815)

8. Yılmaz Erdem,KÖSTEK OSMAN (2018). Frequency of malignancy in radiologic imaging in Type 2

DM patients: preliminary findings. 7th International Trakya Family Medicine Congress, 122-124.

(Tam Metin Bildiri/Sözlü Sunum) (Yayın No: 4821249)

9. KARADAĞ AYŞE SERAP,ÖZLÜ EMİN,KÖSTEK OSMAN,GÜNEŞ BİLGİLİ SERAP,BALAHAROĞLU

RAGIP,ERTUĞRUL DERUN TANER (2017). THE EFFECT OF ACITRETIN TREATMENT ON PITUITARY

10. 9 HORMONES IN PSORIASIS VULGARIS: A NONCONTROLLED STUDY. 2nd International

Dermatology and Cosmetology Congress (Özet Bildiri/Sözlü Sunum) (Yayın No: 3467255)

TAMER HAVVA GONCA,DOĞAN BURCU,OCAKOĞLU İNCİHAN,KÖSTEK OSMAN,İLKAY

KARTAL,SAĞUN HATİCE GÜL,ADAS M,TAMER İSMET,MUTLU HASAN HÜSEYİN,ORHUN A (2014).

Functioning beta cells in type 1 diabetes may not be as low as it is presumed. 50th EASD Annual

Meeting, 57(S1), 189 (Özet Bildiri/Poster) (Yayın No: 5406970)

11. TELCİ ÇAKLILI ÖZGE,KÖSTEK OSMAN,ÖZTÜRK ERMAN,OĞUZ AYTEKİN (2014). A

Pathophysiological Link: Monocyte Count and LDL CholesterolLevels. 10th INTERNATIONAL

CONGRESS OF UPDATE IN CARDIOLOGY AND CARDIOVASCULAR SURGERY, 113(7), 14, Doi:

10.1016/j.amjcard.2014.01.038 (Özet Bildiri/Sözlü Sunum) (Yayın No: 5406717)

12. MESCİ BANU,EREN PINAR,KIZILTAŞ ŞAFAK,OĞUZ AYTEKİN,TUNCER İLYAS,KÖSTEK

OSMAN,ÇOLAK YAŞAR (2013). Association between toll-like receptor 4polymorphism and type 2

diabetes mellitus. 15th European Congress of Endocrinology, 32(P372), 372, Doi:

10.1530/endoabs.32.P372 (Özet Bildiri/Poster) (Yayın No: 5404948)

13. ARPAĞ HÜSEYİN,KUYUCU TULİN,ORDU EMİNE NİLGÜN,KARABAY CAN YUCEL,OĞUZ

AYTEKİN,MESCİ BANU,KÖSTEK OSMAN,KULAKSIZ IŞIK (2012). Serum and Pleural NTproBNP

Levels In Patients withCongestive Heart Failure and Its Contribution toDiagnosis. 3rd World Heart

Failure Congress, 30(S1), 88-88. (Özet Bildiri/Poster) (Yayın No: 5404788)

3.Yazılan uluslararası kitaplar veya kitaplarda bölümler

1. Advances in Diagnosis and Therapy of Colorectal Carcinoma, Bölüm adı:(Treatment of Metastatic

Colorectal Cancer: Beyond Progression) (2024)., GÜREN ALİ KAAN,KÖSTEK OSMAN, intechopen,

Basım sayısı:1, Sayfa Sayısı 22, ISBN:10.5772/intechopen.1004189, İngilizce(Bilimsel Kitap)

(Yayın No: 8962311)

2. ONKOLOJİK ACİLLER, Bölüm adı:(HEDEFE YÖNELİK TEDAVİLERİN ACİL YAN ETKİLERİ) (2020).,

HACIOĞLU MUHAMMET BEKİR,KÖSTEK OSMAN, Akademisyen Kitabevi A.Ş., Basım sayısı:1, Sayfa

Sayısı 400, ISBN:978-605-258-933-5, Türkçe(Bilimsel Kitap) (Yayın No: 8962308)

4.Ulusal hakemli dergilerde yayınlanan makaleler

1. KÖSTEK OSMAN (2023). Relationship between prognostic nutritional index and neutrophil

lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving

regorafenib.. Journal of cancer research and therapeutics, 19(3), 762, Doi:

10.4103/jcrt.jcrt_1620_21 (Kontrol No: 8899024)

2. DEMİRCAN NAZIM CAN,KÖSTEK OSMAN,GÖKYER ALİ,KÜÇÜKARDA AHMET,HACIOĞLU MUHAMMET

BEKİR,ERDOĞAN BÜLENT,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN (2019). The albumin-bilirubin (ALBI)

grade as a significant prognostic factor in colorectal cancer patients with liver metastases. Journal

of Surgery and Medicine, Doi: 10.28982/josam.597751 (Kontrol No: 5675368)

3. GÖKYER ALİ,KÜÇÜKARDA AHMET,KÖSTEK OSMAN (2019). Pür Seminom Vakalarının Klinik

Özellikleri ve Tedavi Sonrası İzlemleri: Tek Merkez Deneyimi. Namık Kemal Tıp Dergisi, 7(2), 128-

132. (Kontrol No: 5387584)

4. ORAL ALİHAN,BAŞÇI SEMİH,KÖSTEK OSMAN,UZUNLULU MEHMET (2019). Clinical characteristics

and overdose risk factors of patients hospitalized due to warfarin overdose. Demiroğlu Bilim

Üniversitesi Florence Nightingale Tıp Dergisi, 5(2), 63-71., Doi: 10.5606/fng.btd.2019.012 (Kontrol

No: 5387707)

5. KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR (2019). Effect of Somatostatin Analogs on Prostate

Volume. Medeniyet Medical Journal, 34(2), 176-181., Doi: 10.5222/MMJ.2019.47700 (Kontrol No:

5395417)

6. ÇALIŞKAN ZUHAL,DEMİRCİOĞLU KENAN,SAYAR SÜLEYMAN,KAHRAMAN RESUL,ÇAKLILI

ÖZGE,ÖZCAN FATMA BETÜL,KÖSTEK OSMAN,BAYCAN ÖMER FARUK,DOĞANAY HAMDİ

LEVENT,ÇALIŞKAN MUSTAFA (2019). Lipid profile atherogenic indeces and their relation of

epicardial fat thickness and carotid intima media thickness in Celiac disease. Northern Clinics of

Istanbul, 6(3), 242-247., Doi: 10.14744/nci.2019.54936 (Kontrol No: 5298339)

7. KÖSTEK OSMAN,TAKIR MÜMTAZ,ÇALIŞKAN MUSTAFA,OĞUZ AYTEKİN (2018). Assessment of

cardiovascular findings in FMF related amyloid patients. Medeniyet Medical Journal, 33(3), 149-

157., Doi: 10.5222/MMJ.2018.05826 (Kontrol No: 5420070)

8. GÖKYER ALİ,KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR,ERDOĞAN BÜLENT,KODAZ

HİLMİ,TURKMEN ESMA,HACIBEKİROĞLU İLHAN,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN (2017). Clinical

Features of the Patient with Multiple Primary Tumors: Single Center Experience. Northern Clinics of

Istanbul, 4(1), 43-51., Doi: 10.14744/nci.2017.67044 (Kontrol No: 5395528)

9. Bilgin Satılmış,Abdullah Özkök,KÖSTEK OSMAN,Başçı Semih,Özkanlı Şeyma,ODABAŞ ALİ RIZA

(2017). Effects of the Clinical and Biochemical Features of Patients with Treatment-Resistant

Primary Nephrotic Syndrome on Renal Survival. Turkish Nephrology Dialysis Transplantation,

26(01), 79-85., Doi: 10.5262/tndt.2017.1001.13 (Kontrol No: 4407390)

10. TAKIR MÜMTAZ,BAKAN ALİ,TAYMAZ TAHRA SEMA,KÖSTEK OSMAN,EREK AYBALA,DURAN

İLYAS,BAKAN SİBEL,ELÇİOĞLU ÖMER CELAL,BAHAT KÜBRA,ODABAŞ ALİ RIZA,KANBAY MEHMET

(2017). Bone Mineral Density and Osteoporosis in Hyponatremic Versus Normonatremic Patients:

A Retrospective 12-Month Analysis. Turkish Nephrology Dialysis Transplantation, 26(1), 29-34.,

Doi: 10.5262/tndt.2017.1001.05 (Kontrol No: 4428745)

11. Erdoğmuş Sema,Mümtaz Takır,KÖSTEK OSMAN,Şenol Serkan,Mutlu Hasan Hüseyin (2016).

Relationship Between Papillary Thyroid Cancer And Hashimoto’s Disease. Medeniyet Medical

Journal, 31(1), 186-191., Doi: 10.5222/MMJ.2016.186 (Kontrol No: 4413482)

12. Mümtaz Takır,Solak Yalçın,Aybala Erek,KÖSTEK OSMAN,Oral Alihan,Elçioğlu Ömer Celal,Bakan

Ali,Afşar Barış,Özkök Abdullah,Jalal Diana,Johnson Richard J,Aydın Bahat Kübra,Odabaş Ali

Rıza,KANBAY MEHMET (2016). Association Between Elevated Serum Uric Acid and Vitamin D

Insufficiency Among the Middle-Aged and Elderly Population. Turkish Nephrology Dialysis

Transplantation, 25(2), 182-186., Doi: 10.5262/tndt.2016.1002.10 (Kontrol No: 4409843)

13. KELEŞ NURŞEN,AKSU FEYZA,AÇIKSARI GÖNÜL,YILMAZ YUSUF,DEMİRCİOĞLU KENAN,KÖSTEK

OSMAN,CEKİN MUHAMMED ESAD,KALCIK MACİT,ÇALIŞKAN MUSTAFA (2016). Is Triglyseride/ HDL

Ratio A Reliable Screening Test for Assesment of Atherosclerotic Risk in Patients With Chronic

Inflammatory Diseases?. Northern Clinics of Istanbul, 3(1), 39-45., Doi: 10.14744/nci.2016.52824

(Kontrol No: 4405009)

14. Nurşen Keleş,Aksu Feyza,Açıksarı Gönül,Demircioğlu Kenan,Yılmaz Yusuf,KÖSTEK OSMAN,Çetin

Muhammed Esad,Kalçık Macit,Kul Şeref,ÇALIŞKAN MUSTAFA (2016). Echocardiographic Epicardial

Fat Thickness Measurement and Cardiovascular Risk Assessment in Patients with Systemic Lupus

Erythematosus. Medeniyet Medical Journal, 31(2), 115-121., Doi: 10.5222/MMJ.2016.1003 (Kontrol

No: 4413484)

15. keleş nurşen,ÇALIŞKAN MUSTAFA,elçioğlu ömer celal,akçakoyun mustafa,bakan ali,KÖSTEK

OSMAN,yılmaz yusuf,demircioğlu kenan,ODABAŞ ALİ RIZA (2016). Sistemik AA Amiloidozlu

Hastalarda Epikardiyal Yağ DokusuKalınlığı, Benek Takibi Ekokardiyografik Parametreleri veYüksek

Duyarlıklı C Reaktif Protein Düzeyleri. MN Kardiyoloji, 23(1), 19-27. (Kontrol No: 4413478)

16. Unal Ali Ugur,KÖSTEK OSMAN,TAKIR MÜMTAZ,ÇAKLILI TELCİ ÖZGE,UZUNLULU MEHMET,OĞUZ

AYTEKİN (2015). Prognosis of patients in a medical intensive care unit. Northern Clinics of

Istanbul, 2(3), 189-195., Doi: 10.14744/nci.2015.79188 (Kontrol No: 4405012)

17. Erdemoğlu Engin,Uzunlulu Mehmet,Oğuz Aytekin,KÖSTEK OSMAN,Telci Çaklılı Özge (2015).

Varfarin tedavisi alan hastalarda koagülasyon testlerinin terapötik aralıkta olma oranı. Medeniyet

Medical Journal, 30(3), 105-109., Doi: 10.5222/MMJ.2015.105 (Kontrol No: 4413487)

18. Ozer Mehmet Nuri,UZUNLULU MEHMET,OĞUZ AYTEKİN,KÖSTEK OSMAN,Akyer E,Takır M (2015).

The effect of sociodemographic and clinical features on mortality in patients with diagnosis of

aspiration pneumonia. Northern Clinics of Istanbul, 2(1), 41-47., Doi: 10.14744/nci.2015.41713

(Kontrol No: 4407371)

19. Ozkok Abdullah,Isbilen Banu,Erdemoglu Engin,Ozberk Onur Mihrimah,Çaklili Ozge,KÖSTEK

OSMAN,Elcioglu Omer Celal,Bakan Ali,Atilgan Kadir Gokhan,Sasak Gulsah,Alisir Ecder

Sabahat,Isman Ferruh,KANBAY MEHMET,ODABAŞ ALİ RIZA (2014). Leptin Parameters are

Associated with Inflammation and Both Anthropometric and Serum Markers of Protein-Energy

Wasting in Hemodialysis Patients. Turkish Nephrology Dialysis Transplantation, 23(2), 85-90., Doi:

10.5262/tndt.2014.1002.02 (Kontrol No: 4413492)

1. KÖSTEK OSMAN (2019). MALİGN MELANOM-HEDEFE YÖNELİK TEDAVİDE TARTIŞMALI KONULAR- 4. 3.

MUĞLA MULTİDİSİPLİNER ONKOLOJİK ARAŞTIRMALAR KONGRESİ (AMORE 2019), 58-62. (Tam Metin

Bildiri/Davetli Konuşmacı) (Yayın No: 5405272)

2. KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR (2019). PAZOPANİBİN TEDAVİ ETKİNLİĞİ

DEĞERLENDİRMEDE SİSTEMİK İNFLAMASYON BELİRTEÇLERİ. KONYA MULTİDİSİPLİNER ONKOLOJİ

SEMPOZYUMU (Özet Bildiri/Sözlü Sunum) (Yayın No: 5378434)

3. ALKAN ALİ,SEVGEN GÜÇ ZEYNEP,GÜRBÜZ MUSTAFA,ÖZGÜN GÜLİZ,DEĞİRMENCİOĞLU SERKAN,DOĞAN

MUTLU,AKIN TELLİ TUĞBA,KESKİN ÖZGE,ARSLAN ÇAĞATAY,BİLGİN BURAK,SEZGİN GÖKSU SEMA,DEMİR

HACER,KÖKSOY ELİF BERNA,KÖSTEK OSMAN,ERTÜRK İSMAİL,ŞAKALAR TEOMAN,KARAOĞLU

AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,YUMUK PERRAN FULDEN,ŞENDUR MEHMET ALİ

NAHİT,COŞKUN HASAN ŞENOL,ÇİÇİN İRFAN,KARADURMUŞ NURİ,TANRIVERDİ ÖZGÜR,AKBULUT

HAKAN,ÜRÜN YÜKSEL (2019). Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik

(≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi. 23. ULUSAL

KANSER KONGRESİ, 185 (Özet Bildiri/Sözlü Sunum) (Yayın No: 5405267)

4. ÖZLER TALAR,SAYNAK MERT,NURLU DİLEK,DEMİR SEDA,KÖSTEK OSMAN,KARAMUSTAFAOĞLU YEKTA

ALTEMUR,UZAL MUSTAFA CEM,KOÇAK ZAFER (2019). OPERE ERKEN EVRE KÜÇÜK HÜCRELİ DIŞI

AKCİĞERKANSERLERİNDE LOKAL/BÖLGESEL YİNELEMEPATERNLERİ. 23. ULUSAL KANSER KONGRESİ,

272 (Özet Bildiri/Sözlü Sunum) (Yayın No: 5405268)

5. ALKAN ALİ,SEVGEN GÜÇ ZEYNEP,GÜRBÜZ MUSTAFA,ÖZGÜN GÜLİZ,DEĞİRMENCİOĞLU SERKAN,DOĞAN

MUTLU,AKIN TELLİ TUĞBA,KESKİN ÖZGE,ARSLAN ÇAĞATAY,BİLGİN BURAK,SEZGİN GÖKSU SEMA,DEMİR

HACER,KÖKSOY ELİF BERNA,KÖSTEK OSMAN,ERTÜRK İSMAİL,ŞAKALAR TEOMAN,KARAOĞLU AZİZ,

ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,YUMUK PERRAN FULDEN,ŞENDUR MEHMET ALİ NAHİT,COŞKUN

HASAN ŞENOL,ÇİÇİN İRFAN,KARADURMUŞ NURİ,TANRIVERDİ ÖZGÜR,AKBULUT HAKAN,ÜRÜN YÜKSEL

(2019). GERİATRİK (≥75 YAŞ), KASTRASYON DİRENÇLİMETASTATİK PROSTAT KANSERİ

(KDMPK)HASTALARINDA 1. BASAMAK ANTİ- ANDROJENTEDAVİ SONUÇLARI- GERÇEK YAŞAM VERİSİ. 23.

ULUSAL KANSER KONGRESİ, 300 (Özet Bildiri/Sözlü Sunum) (Yayın No: 5405270)

6. DEMİR TARIK,ARAZ MURAT,KÖSTEK OSMAN,SAKİN ABDULLAH,SHBAİR ABDALLAH TM,ALİYEV

ALTAY,ÇOBAN EZGİ,BEŞİROĞLU MEHMET,ŞEKER MESUT,TÜRK HACI MEHMET (2019). Renal Hücreli

Karsinoma Hastalarında Nefrektomi Esnasında Lenf Nodu DiseksiyonuGerekli mi?. 23. ULUSAL KANSER

KONGRESİ (Özet Bildiri/Sözlü Sunum) (Yayın No: 5378167)

7. SARI MURAT,KÖSTEK OSMAN (2019). Türkiye’de Yaşa Özgü Akciğer Kanseri İnsidans Oranları:Yaşlılarda

Akciğer Kanseri Artmaktadır. Ulusal Akciğer Sağlığı Kongresi 2019, 127-128. (Özet Bildiri/Sözlü Sunum)

(Yayın No: 5396669)

8. Demircan Nazım Can, Köstek Osman (2018). Karaciğere Metastatik Kolorektal Kanserde ALBI Skorunun

Prognostik Önemi. 2. Ulusal İmmünoterapi ve Onkoloji Kongresi, 18-19., Doi:

10.14744/ejmo.2018.2018/ (Özet Bildiri/Sözlü Sunum) (Yayın No: 4821273)

9. KÖSTEK OSMAN,HACIOĞLU MUHAMMET BEKİR,SAKİN ABDULLAH,DEMİR TARIK,SARI MURAT,ÖZKUL

ÖZLEM,ARAZ MURAT,DEMİRCAN NAZIM CAN (2018). Metastatik Kolorektal Kanser Tedavisinde3.

Basamak: Yeniden Kemoterapi VsRegorafenib. 2. Ulusal İmmünoterapi ve Onkoloji Kongresi (Özet

Bildiri/Sözlü Sunum) (Yayın No: 4866006)

10. Yılmaz Erdem,KÖSTEK OSMAN (2018). Can we predict the timing of hepatospecific contrast agent

appearance in the bile duct before MRI?. Turkish society of magnetic resonance 23rd annual meeting,

50, 137-137. (Özet Bildiri/Sözlü Sunum) (Yayın No: 4821257)

11. Yılmaz Erdem,KÖSTEK OSMAN (2018). Malign melanom hastalarında pineal gland kalsifikasyonu sıklık

ve prognoz ile ilişkisi. Türk Nöroradyoloji Derneği 27. yıl yıllık toplantısı nöroradyoloji ve baş-boyun

radyolojisi, 24 (Özet Bildiri/Sözlü Sunum) (Yayın No: 4821264)

12. VURAL KESKİNLER MİRAÇ,BULUR SERKAN,KÖSTEK OSMAN,BERRİN EROK,CAN ORÇUN,DANACIOĞLU

YAVUZ ONUR,OĞUZ AYTEKİN (2013). The Impact of Non-Cardiac Surgery on Electrocardiograph

Changes, Troponin Levels in patients with Intermediate and High Risk According to Framingham

General Cardiovascular Disease Risk Score. TURKISH SOCIETY OF CARDIOLOGY, 62(18), 191, Doi:

10.1016/j.jacc.2013.08.544 (Özet Bildiri/Poster) (Yayın No: 5404999)

13. FEYİZOĞLU GÜNEŞ,DOĞAN BURCU,FEYİZOĞLU HALİL,TELCİ ÇAKLILI ÖZGE,KÖSTEK OSMAN,OĞUZ

AYTEKİN (2013). Diabetes risk awareness of general population. 10th MetabolicSyndrome Symposium,

15(3), 235-235. (Özet Bildiri/Poster) (Yayın No: 5404877)

14. TELCİ ÇAKLILI ÖZGE,ÖZATA MERVE,ARSLAN BAHADIR MÜZEYYEN,KÖSTEK OSMAN,OĞUZ AYTEKİN

(2013). Does individualized education on diabetes improveglycemic control?. 10th MetabolicSyndrome

Symposium, 15(3), 241-241. (Özet Bildiri/Poster) (Yayın No: 5404911)

15. KESKİN HAVVA,ÇARLIOĞLU AYŞE,KARAKILIÇ ULUDAĞ EDA ÜLKÜ,KABİL KUCUR SUNA,GÖZÜKARA

İLAY,KAYA YASEMİN,ALBAYRAK FATİH,HATİCE GÜL SAĞUN,MESCİ BANU,MÜMTAZ TAKIR,KÖSTEK OSMAN

(2013). Obesity is the main culprit in polycysticovary syndrome?. 10th MetabolicSyndrome

Symposium, 15(3), 271-271. (Özet Bildiri/Poster) (Yayın No: 5404925)

16. YAVUZ GÜLCAN,OĞUZ AYTEKİN,TELCİ ÇAKLILI ÖZGE,KÖSTEK OSMAN (2013). Diabetes mellitus

knowledge of nurses. 10th MetabolicSyndrome Symposium, 15(3), 235-235. (Özet Bildiri/Poster) (Yayın

No: 5404848)

17. KÖSTEK OSMAN,OĞUZ AYTEKİN,MESCİ BANU,ATEŞ MEHMET,GENÇTURK NİHAN,TELCİ ÇAKLILI

ÖZGE,ULUS CANSU,ALKAYA GÜNEŞ (2012). Nutritional perception and practice differences indieting.

9th MetabolicSyndrome Symposium, 13(7), 652 (Özet Bildiri/Poster) (Yayın No: 5404065)

18. OĞUZ AYTEKİN,MESCİ BANU,GENCTURK NİHAN,ULUS CANSU,ATEŞ MEHMET,KÖSTEK OSMAN,TELCİ

ÇAKLILI ÖZGE (2012). Prevalence of abdominal obesity, high bloodpressure and dysglycaemia in

hospitalizedpatients. 9th MetabolicSyndrome Symposium, 13(7), 653-653. (Özet Bildiri/Poster) (Yayın

No: 5404098)

19. MESCİ BANU,OĞUZ AYTEKİN,KAVALA MUKADDES,İŞBİLEN BANU,İŞMAN FERRUH KEMAL,SADIGOV

FARİZ,KÖSTEK OSMAN,ÇOKSERT KILIÇ DAMLA (2012). Metabolic evaluation of patients with

Behcet’sdisease. 9th MetabolicSyndrome Symposium, 13(7), 651-651. (Özet Bildiri/Poster)

20. MESCİ BANU,AGURASLAN EMRE,KARACA MEHMET,ZENGİN AHMET,TUSUN EYUP,KÖSTEK OSMAN,TELCİ

ÇAKLILI ÖZGE,OĞUZ AYTEKİN (2012). The problems of oral anticoagulation in patientswith metabolic

syndrome, hypertension ordiabetes mellitus. 9th Metabolic Syndrome Symposium, 13(7), 650-650.,

Doi: 10.1111/j.1467-789X.2012.01006.x (Özet Bildiri/Poster) (Yayın No: 5404012)

21. MESCİ BANU,OĞUZ AYTEKİN,GENCTURK NİHAN,ATEŞ MEHMET,ULUS CANSU,TELCİ ÇAKLILI

ÖZGE,KÖSTEK OSMAN (2012). Extra foods and drinks of diabetic patients in thehospital. 9th

MetabolicSyndrome Symposium, 13(7), 652-652. (Özet Bildiri/Poster) (Yayın No: 5404088)

5. Ulusal bilimsel toplantılarda sunulan ve bildiri kitabında basılan bildiriler